Form D · Biotechnology
NEONC TECHNOLOGIES HOLDINGS, INC.
Calabasas, CA · CIK 0001979414
Offering snapshot reported Jun 25, 2026 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 10, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2026 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
| Feb 9, 2026 | Initial | $10,621,804 | No comparison | 4 | SEC filing |
| Dec 18, 2025 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Apr 11, 2025 | Initial | $1,644,000 | No comparison | 7 | SEC filing |
| Mar 24, 2025 | Initial | $9,999,984 | No comparison | 13 | SEC filing |
| Oct 28, 2024 | Initial | $18,341,332 | No comparison | 32 | SEC filing |
| Jul 5, 2023 | Initial | $80,000,000 | No comparison | 67 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $400K
- Finders' fees
- $0
- Form D file number
- 021-588679
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Dawson James Securities, Inc. | 000130645 |
Source: Form D, filed Jun 25, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bader Almonawer | Director |
| Bader Al Monawer | Director |
| Thomas C Chen | Director, Executive |
| Ming Fu (Alan) Chiang | Director |
| Alan Chiang | Director |
| Ming Fu Chiang | Director |
| David Choi | Executive |
| Jim Delshad | Director |
| Keithly Garnett | Executive |
| Steven L. Giannotta | Director |
| Amir F. Heshmatpour | Director, Executive |
| Victoria Medvec | Director |
| Yousha Neman Ebrahim | Executive |
| Ishwar Kanwar Puri | Director |
| Patrick Walters | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
23975 Park Sorrento Suite 205
Calabasas, CA, 91302
Calabasas, CA, 91302